HistCite - The Kidney Transplant Papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1601	2536 Matas AJ, Payne WD, Sutherland DER, Humar A, Gruessner RWG, et al. 2,500 living donor kidney transplants: A single-center experience ANNALS OF SURGERY. 2001 AUG; 234 (2): 149-164	0	85	3	47
1602	2547 Matas AJ, Ramcharan T, Paraskevas S, Gillingham KJ, Dunn DL, et al. Rapid discontinuation of steroids in living donor kidney transplantation: A pilot study AMERICAN JOURNAL OF TRANSPLANTATION. 2001 SEP; 1 (3): 278-283	5	73	3	22
1603	2796 Matas AJ, Kandaswamy R, Humar A, Payne WD, Dunn DL, et al. Long-term immunosuppression, without maintenance prednisone, after kidney transplantation ANNALS OF SURGERY. 2004 SEP; 240 (3): 510-516	2	61	4	42
1604	1777 Mathe G Will killing the last HIV1 particle cure AIDS patients? Doesn't CMV activation and/or a graft-versus-host component of the disease, also have to be considered? .1. First of two parts BIOMEDICINE & PHARMACOTHERAPY. 1996; 50 (5): 185-206	0	6	4	140
1605	2621 Mathes DW, Randolph MA, Bourget JL, Nielsen GP, Ferrera VR, et al. Recipient bone marrow engraftment in donor tissue after long-term tolerance to a composite tissue allograft TRANSPLANTATION. 2002 JUN 27; 73 (12): 1880-1885	13	17	8	31
1606	1994 Mathew JM, Carreno M, Fuller L, Ricordi C, Tzakis AG, et al. Modulatory effects of human donor bone marrow cells on allogeneic cellular immune responses TRANSPLANTATION. 1997 MAR 15; 63 (5): 686-692	18	35	5	42
1607	2137 Mathew JM, Carreno M, Zucker K, Fuller L, Kenyon N, et al. Cellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantation TRANSPLANTATION. 1998 APR 15; 65 (7): 947-955	11	19	6	30
1608	2158 Mathew JM, Carreno M, Zucker K, Fuller L, Vallone T, et al. Differential resistance of the cellular immune responses and immunoregulatory properties of human cadaveric donor bone marrow cells to immunosuppressive drugs commonly used in transplantation TRANSPLANTATION PROCEEDINGS. 1998 JUN; 30 (4): 1073-1074	0	1	3	8
1609	2344 Mathew JM, Carreno M, Fuller L, Ricordi C, Kenyon N, et al. In vitro immunogenicity of cadaver donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation TRANSPLANTATION. 1999 OCT 27; 68 (8): 1172-1180	7	12	6	32
1610	2469 Mathew JM, Garcia-Morales R, Fuller L, Rosen A, Ciancio G, et al. Donor bone marrow-derived chimeric cells present in renal, transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses TRANSPLANTATION. 2000 DEC 27; 70 (12): 1675-1682	15	36	13	29
#	Date / Author / Journal	LCS	GCS	LCR	CR
1611	2470 Mathew JM, Fuller L, Carreno M, Garcia-Morales R, Burke GW, et al. Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses TRANSPLANTATION. 2000 DEC 27; 70 (12): 1752-1760	9	22	13	37
1612	2530 Mathew JM, Miller J Immunoregulatory role of chimerism in clinical organ transplantation BONE MARROW TRANSPLANTATION. 2001 JUL; 28 (2): 115-119	8	14	19	48
1613	2637 Mathew JM, Carreno M, Fuller L, Burke GW, Ciancio G, et al. Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparations used in clinical organ transplantation TRANSPLANTATION. 2002 SEP 27; 74 (6): 846-855	4	7	12	34
1614	2715 Mathew JM, Garcia-Morales RO, Carreno M, Jin YD, Fuller L, et al. Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation TRANSPLANT IMMUNOLOGY. 2003 JUL-SEP; 11 (3-4): 307-321	6	19	24	64
1615	3065 Mathew JM, Blomberg B, Ricordi C, Esquenazi V, Miller J Evaluation of the tolerogenic effects of donor bone marrow cells using a severe combined immunodeficient mouse-human islet transplant model HUMAN IMMUNOLOGY. 2008 OCT; 69 (10): 605-613	0	0	14	41
1616	3154 Mathew JM, Ciancio G, Burke GW, Garcia-Morales RO, Rosen A, et al. Immune "tolerance profiles" in donor bone marrow infused kidney transplant patients using multiple ex vivo functional assays HUMAN IMMUNOLOGY. 2010 JUN; 71 (6): 566-576	2	4	12	37
1617	3194 Mathew JM, Leventhal JR, Miller J Microchimerism in promoting graft acceptance in clinical transplantation CURRENT OPINION IN ORGAN TRANSPLANTATION. 2011 AUG; 16 (4): 345-352	0	0	36	90
1618	1388 MATHEWS KA, GALLIVAN GJ, MALLARD BA CLINICAL, BIOCHEMICAL, AND HEMATOLOGIC EVALUATION OF NORMAL DOGS AFTER ADMINISTRATION OF RABBIT ANTI-DOG THYMOCYTE SERUM VETERINARY SURGERY. 1993 MAY-JUN; 22 (3): 213-220	0	5	3	39
1619	1113 MATHIESON PW, REES AJ CHANGING VIEWS ON THE TREATMENT OF GLOMERULONEPHRITIS INTERNATIONAL YEARBOOK OF NEPHROLOGY. 1991; : 73-95	0	0	1	175
1620	1987 Mathieu C, Casteels K, Bouillon R, Waer M Protection against autoimmune diabetes in mixed bone marrow chimeras - Mechanisms involved JOURNAL OF IMMUNOLOGY. 1997 FEB 1; 158 (3): 1453-1457	1	23	5	24
#	Date / Author / Journal	LCS	GCS	LCR	CR
1621	2245 Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, et al. Impact of hepatitis B and C virus on kidney transplantation outcome HEPATOLOGY. 1999 JAN; 29 (1): 257-263	3	270	3	34
1622	1465 MATSUNAMI H, TADA A, MAKUUCHI M, LYNCH SV, STRONG RW NEW TECHNIQUE FOR MEASURING TACROLIMUS CONCENTRATIONS IN BLOOD AMERICAN JOURNAL OF HOSPITAL PHARMACY. 1994 JAN; 51 (1): 123-123	1	1	3	4
1623	1216 MATSUURA T, SHINOHARA Y, HARA Y, IMANISHI M, NISHIOKA T, et al. BENEFICIAL IMMUNOSUPPRESSIVE EFFECT OF COMBINED USE OF FK-506 AND CYCLOSPORINE ASSESSED BY PROLIFERATIVE RESPONSES OF CLONED HUMAN T-CELLS TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 2931-2932	0	0	4	9
1624	1270 MATSUURA T, NEGITA M, IKEGAMI M, IMANISHI M, NISHIOKA T, et al. BLOCKADE OF INTERLEUKIN-2 PRODUCTION FROM CLONED T-CELLS BY CYCLOSPORINE AND FK-506 ASSESSED BY PROLIFERATION ASSAYS INVITRO TRANSPLANTATION PROCEEDINGS. 1992 FEB; 24 (1): 410-412	0	1	2	13
1625	1456 MATSUURA T, HARA Y, IMANISHI M, KANDA H, KURITA T PROLONGED SURVIVAL OF RAT CARDIAC ALLOGRAFTS INDUCED BY INTRATHYMIC INJECTION OF DONOR BONE-MARROW CELLS TRANSPLANTATION PROCEEDINGS. 1993 DEC; 25 (6): 3283-3285	2	6	1	13
1626	2043 Matsuura T, Imanishi M, Hara Y, Nishioka T, Kunikata S, et al. Suppressed alloreactivity and mixed chimerism in rats with accepted cardiac allografts by intrathymic injection of donor bone marrow cells TRANSPLANT INTERNATIONAL. 1997 JUL; 10 (4): 262-267	1	3	3	22
1627	2335 Matteucci E, Carmellini M, Mosca F, Giampietro O The contribution of Na+/H+ exchange to postreperfusion injury and recovery of transplanted kidney BIOMEDICINE & PHARMACOTHERAPY. 1999 OCT; 53 (9): 438-444	0	2	2	35
1628	2148 Mayr WR, Glock B DNA typing of patients with potentially modified patterns in peripheral blood TRANSFUSION. 1998 MAY; 38 (5): 510-510	0	1	1	4
1629	1862 Mayumi H, Umesue M, Nomoto K Cyclophosphamide-induced immunological tolerance: An overview IMMUNOBIOLOGY. 1996 JUL; 195 (2): 129-139	2	44	5	73
1630	1643 MAZARIEGOS GV, RAMOS H, SHAPIRO R, ZEEVI A, FUNG JJ, et al. WEANING OF IMMUNOSUPPRESSION IN LONG-TERM RECIPIENTS OF LIVING-RELATED RENAL-TRANSPLANTS - A PRELIMINARY-STUDY TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 207-209	15	31	7	24
#	Date / Author / Journal	LCS	GCS	LCR	CR
1631	1951 Mazariegos GV, Reyes J, Marino IR, Demetris AJ, Flynn B, et al. Weaning of immunosuppression in liver transplant recipients TRANSPLANTATION. 1997 JAN 27; 63 (2): 243-249	77	207	16	19
1632	1975 Mazariegos GV, Reyes J, Marino I, Flynn B, Fung JJ, et al. Risks and benefits of weaning immunosuppression in liver transplant recipients: Long-term follow-up TRANSPLANTATION PROCEEDINGS. 1997 FEB-MAR; 29 (1-2): 1174-1177	9	26	9	13
1633	2427 Mazariegos GV, Salzedas AA, Zavatsky J, Sindhi R, Parizhskaya M, et al. Long term management of liver transplant rejection in children BIODRUGS. 2000 JUL; 14 (1): 31-48	0	5	20	80
1634	2707 Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L, Flynn B, et al. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients AMERICAN JOURNAL OF TRANSPLANTATION. 2003 JUN; 3 (6): 689-696	19	89	9	41
1635	2787 Mazariegos GV Withdrawal of immunosuppression in liver transplantation: Lessons learned from PTLD PEDIATRIC TRANSPLANTATION. 2004 JUN; 8 (3): 210-213	2	7	14	41
1636	2795 Mazariegos GV, Abu-Elmagd K, Jaffe R, Bond G, Sindhi R, et al. Graft versus host disease in intestinal transplantation AMERICAN JOURNAL OF TRANSPLANTATION. 2004 SEP; 4 (9): 1459-1465	7	28	8	39
1637	2947 Mazariegos GV Tolerogenic immunosuppression in pediatric abdominal transplantation CURRENT OPINION IN ORGAN TRANSPLANTATION. 2006 OCT; 11 (5): 537-542	0	0	18	38
1638	2972 Mazariegos GV, Sindhi R, Thomson AW, Marcos A Clinical tolerance following liver transplantation: Long term results and future prospects TRANSPLANT IMMUNOLOGY. 2007 FEB; 17 (2): 114-119	13	32	21	46
1639	1055 MAZZAFERRO V, SCOTTIFOGLIENI CL, PORTER KA, BELLIDO JT, CARRIERI G, et al. STUDIES OF THE HEPATOTROPHIC QUALITIES OF FK-506 AND CYA TRANSPLANTATION PROCEEDINGS. 1990 FEB; 22 (1): 93-95	5	19	1	12
1640	1815 Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis NEW ENGLAND JOURNAL OF MEDICINE. 1996 MAR 14; 334 (11): 693-699	6	2143	2	33
#	Date / Author / Journal	LCS	GCS	LCR	CR
1641	2894 McCall J Genetic algorithms for modelling and optimisation JOURNAL OF COMPUTATIONAL AND APPLIED MATHEMATICS. 2005 DEC 1; 184 (1): 205-222	0	23	2	37
1642	2602 McCaughan GW Withdrawal of immunosuppression in liver transplant recipients: Is this as good as it gets? LIVER TRANSPLANTATION. 2002 APR; 8 (4): 408-410	5	7	10	14
1643	1025 MCCAULEY J, BRONSTHER O, Fung JJ, TODO S, STARZL TE TREATMENT OF CYCLOSPORIN-INDUCED HEMOLYTIC UREMIC SYNDROME WITH FK506 LANCET. 1989 DEC 23; 2 (8678-9): 1516-1516	9	66	3	8
1644	1045 MCCAULEY J, Fung JJ, JAIN A, TODO S, STARZL TE THE EFFECTS OF FK-506 ON RENAL-FUNCTION AFTER LIVER-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1990 FEB; 22 (1): 17-20	41	90	1	11
1645	1148 MCCAULEY J, TAKAYA S, Fung JJ, Tzakis AG, ABUELMAGD K, et al. THE QUESTION OF FK506 NEPHROTOXICITY AFTER LIVER-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1991 FEB; 23 (1): 1444-1447	21	50	5	19
1646	1239 MCCAULEY J, FUNG JJ, TODO S, JAIN A, DEBALLI P, et al. CHANGES IN RENAL-FUNCTION AFTER LIVER-TRANSPLANTATION UNDER FK-506 TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3143-3145	16	44	5	8
1647	1254 MCCAULEY J, SHAPIRO R, SCANTLEBURY V, GILBOA N, JORDAN M, et al. FK-506 IN THE MANAGEMENT OF TRANSPLANT-RELATED NEPHROTIC SYNDROME AND STEROID-RESISTANT NEPHROTIC SYNDROME TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3354-3356	5	18	3	6
1648	2828 McCauley J Steroid-free lymphocyte depletion protocols - The potential for partial tolerance? KIDNEY TRANSPLANTATION : STRATEGIES TO PREVENT ORGAN REJECTION. 2005; 146: 43-53	0	3	6	35
1649	1520 MCCHESNEY LP, XIAO F, SANKARY HN, FOSTER PF, SHARMA S, et al. AN EVALUATION OF LEFLUNOMIDE IN THE CANINE RENAL-TRANSPLANTATION MODEL TRANSPLANTATION. 1994 JUN 27; 57 (12): 1717-1722	1	58	3	23
1650	2874 McCurry KR, Iacono A, Zeevi A, Yousem S, Girnita A, et al. Early outcomes in human lung transplantation with thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 2005 AUG; 130 (2): 528-537	11	59	5	22
#	Date / Author / Journal	LCS	GCS	LCR	CR
1651	2931 McCurry KR, Colvin BL, Zahorchak AF, Thomson AW Regulatory dendritic cell therapy in organ transplantation TRANSPLANT INTERNATIONAL. 2006 JUL; 19 (7): 525-538	1	40	9	115
1652	1224 MCDIARMID SV, KLINTMALM G, BUSUTTIL RW FK-506 RESCUE THERAPY IN LIVER-TRANSPLANTATION - OUTCOME AND COMPLICATIONS TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 2996-2999	10	27	4	10
1653	1437 MCDIARMID SV, COLONNA JO, SHAKED A, AMENT ME, BUSUTTIL RW A COMPARISON OF RENAL-FUNCTION IN CYCLOSPORINE-TREATED AND FK-506-TREATED PATIENTS AFTER PRIMARY ORTHOTOPIC LIVER-TRANSPLANTATION TRANSPLANTATION. 1993 OCT; 56 (4): 847-853	14	73	15	50
1654	1677 MCDIARMID SV, WALLACE P, VARGAS J, AMENT ME, BUSUTTIL RW THE TREATMENT OF INTRACTABLE REJECTION WITH TACROLIMUS (FK506) IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 1995 APR; 20 (3): 291-299	3	22	23	61
1655	2108 McDiarmid SV The use of tacrolimus in pediatric liver transplantation JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 1998 JAN; 26 (1): 90-102	5	22	26	97
1656	2740 McDiarmid SV Current status of liver transplantation in children PEDIATRIC CLINICS OF NORTH AMERICA. 2003 DEC; 50 (6): 1335-+	3	33	11	265
1657	1690 MCDONALD JC IN SEARCH OF THE HOLY-GRAIL (ACTIVELY ACQUIRED IMMUNOLOGICAL-TOLERANCE) ANNALS OF SURGERY. 1995 MAY; 221 (5): 439-445	0	3	3	45
1658	2065 McDonald JC, Adamashvili I, Zibari GB, Aultman DF, Mancini MC, et al. Serologic allogeneic chimerism TRANSPLANTATION. 1997 SEP 27; 64 (6): 865-871	2	9	5	38
1659	926 MCENERY PT, FINE R, ASCHER N, ETTENGER R, CONLEY S, et al. RENAL-TRANSPLANT IMMUNITY AND IMMUNOSUPPRESSION AMERICAN JOURNAL OF KIDNEY DISEASES. 1986 APR; 7 (4): 312-317	0	2	5	27
1660	1285 MCGOON MD, FRANTZ RP TECHNIQUES OF IMMUNOSUPPRESSION AFTER CARDIAC TRANSPLANTATION MAYO CLINIC PROCEEDINGS. 1992 JUN; 67 (6): 586-595	0	6	3	47
#	Date / Author / Journal	LCS	GCS	LCR	CR
1661	602 MCGRATH BP, IBELS LS, RAIK E, HARGRAVE M, MAHONY JF, et al. ERYTHROID TOXICITY OF AZATHIOPRINE - MACROCYTOSIS AND SELECTIVE MARROW HYPOPLASIA QUARTERLY JOURNAL OF MEDICINE. 1975; 44 (173): 57-63	0	50	2	17
1662	2011 McKee M, Segev D, Wise B, Case B, Neu A, et al. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients JOURNAL OF PEDIATRIC SURGERY. 1997 MAY; 32 (5): 688-690	0	26	3	8
1663	237 MCKENZIE IF, STOCKER J, TING A, MORRIS PJ HUMAN LYMPHOCYTOTOXIC AND HAEMAGGLUTINATING ACTIVITY AGAINST SHEEP AND PIG CELLS LANCET. 1968; 2 (7564): 386-&	1	23	1	13
1664	823 MCMASTER P, HAYNES IG, MICHAEL J, ADU D, VLASSIS T, et al. CYCLOSPORINE IN CADAVERIC RENAL-TRANSPLANTATION - A PROSPECTIVE RANDOMIZED TRIAL TRANSPLANTATION PROCEEDINGS. 1983; 15 (4): 2523-2527	4	35	4	14
1665	1426 MCMASTER P, BUIST L FK-506 IN TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 2684-2685	4	10	2	6
1666	1760 MCMASTER P, MIRZA DF, ISMAIL T, VENNARECCI G, PATAPIS P, et al. THERAPEUTIC DRUG-MONITORING OF TACROLIMUS IN CLINICAL TRANSPLANTATION THERAPEUTIC DRUG MONITORING. 1995 DEC; 17 (6): 602-605	8	61	2	8
1667	1411 MCMICHAEL J, LIEBERMAN R, DOYLE H, MCCAULEY J, Fung JJ, et al. AN INTELLIGENT AND COST-EFFECTIVE COMPUTER DOSING SYSTEM FOR INDIVIDUALIZING FK506 THERAPY IN TRANSPLANTATION AND AUTOIMMUNE DISORDERS JOURNAL OF CLINICAL PHARMACOLOGY. 1993 JUL; 33 (7): 599-605	1	8	3	20
1668	1750 MCNAIR ANB, TIBBS CJ, WILLIAMS R RECENT ADVANCES - HEPATOLOGY BRITISH MEDICAL JOURNAL. 1995 NOV 18; 311 (7016): 1351-1355	0	1	2	48
1669	400 MCPHAUL JJ, DIXON FJ, BRETTSCH.L, STARZL TE IMMUNOFLUORESCENT EXAMINATION OF BIOPSIES FROM LONG-TERM RENAL ALLOGRAFTS NEW ENGLAND JOURNAL OF MEDICINE. 1970; 282 (8): 412-&	8	44	7	23
1670	3088 McShane PJ, Garrity ER Minimization of immunosuppression after lung transplantation: current trends TRANSPLANT INTERNATIONAL. 2009 JAN; 22 (1): 90-95	0	1	9	41
#	Date / Author / Journal	LCS	GCS	LCR	CR
1671	1936 McSherry C, Jackson A, Hertz MI, Boltman R, Savik K, et al. Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function TRANSPLANTATION. 1996 DEC 27; 62 (12): 1811-1818	7	24	16	43
1672	3049 Mehrabi A, Fonouni H, Muller SA, Schmidt J Current concepts in transplant surgery: liver transplantation today LANGENBECKS ARCHIVES OF SURGERY. 2008 MAY; 393 (3): 245-260	0	13	4	93
1673	3132 Mehrabi A, Fonouni H, Ayoub E, Rahbari NN, Muller SA, et al. A single center experience of combined liver kidney transplantation CLINICAL TRANSPLANTATION. 2009 DEC; 23: 102-114	0	2	9	153
1674	2355 Mehta P, Beltz S, Kedar A, Graham-Pole J, Wingard JR Increased clearance of tacrolimus in children: need for higher doses and earlier initiation prior to bone marrow transplantation BONE MARROW TRANSPLANTATION. 1999 DEC; 24 (12): 1323-1327	0	11	4	11
1675	1417 MEISER B, REICHART B GRAFT VESSEL DISEASE - THE IMPACT OF IMMUNOSUPPRESSION AND POSSIBLE TREATMENT STRATEGIES IMMUNOLOGICAL REVIEWS. 1993 AUG; 134: 99-116	0	12	3	75
1676	2361 Melief CJM, Toes REM, Medema JP, Van der Burg SH, Ossendorp F, et al. Strategies for immunotherapy of cancer ADVANCES IN IMMUNOLOGY, VOL 75. 2000; 75: 235-282	1	122	1	283
1677	375 MEMPEL W, THIERFEL.S EFFECT OF ANTILYMPHOCYTE SERUM ALONE OR IN CONNECTION WITH A CYTOSTATICUM ON A LEUKEMIA OF MICE BLUT. 1970; 20 (1): 37-&	1	5	3	16
1678	928 MENDEZ R, KOUSSA N, ALANIZI A, MENDEZ RG, IWAKI Y, et al. PERIOPERATIVE CYCLOSPORINE - INTERACTION WITH MULTIFACTORIAL VARIABLES AND EFFECT ON ALLOGRAFT FUNCTION TRANSPLANTATION PROCEEDINGS. 1986 APR; 18 (2): 12-15	1	4	1	6
1679	361 MERIEL ANESTHESIA ON NEPHRITIC PATIENT ANESTHESIE ANALGESIE REANIMATION. 1970; 27 (2): 241-&	0	0	1	44
1680	815 MERION RM, WHITE DJG, CALNE RY EARLY RENAL-ALLOGRAFT REJECTION EPISODES ARE LESS AGGRESSIVE WITH CYCLOSPORIN-A IMMUNOSUPPRESSION TRANSPLANTATION PROCEEDINGS. 1983; 15 (4): 2172-2177	3	9	5	12
#	Date / Author / Journal	LCS	GCS	LCR	CR
1681	863 MERION RM, WHITE DJG, THIRU S, EVANS DB, CALNE RY CYCLOSPORINE - 5 YEARS EXPERIENCE IN CADAVERIC RENAL-TRANSPLANTATION NEW ENGLAND JOURNAL OF MEDICINE. 1984; 310 (3): 148-154	25	386	6	28
1682	634 MERKEL FK, STRAUS AK, ANDERSEN O, BANNETT AD MICROVASCULAR TECHNIQUES FOR POLAR ARTERY RECONSTRUCTION IN KIDNEY-TRANSPLANTS SURGERY. 1976; 79 (3): 253-261	5	34	3	11
1683	64 MERRILL JP EXPERIENCE IN RENAL TRANSPLANTATION NEW ENGLAND JOURNAL OF MEDICINE. 1965; 272 (21): 1134-&	0	0	1	1
1684	114 MERRILL JP, FLAX MH, PIER AS, CANELLOS GP, LEAF A, et al. WEEKLY CLINICOPATHOLOGICAL EXERCISES - CASE 43-1966 NEW ENGLAND JOURNAL OF MEDICINE. 1966; 275 (13): 721-&	0	2	2	10
1685	1172 METCALFE S, MILNER J EVIDENCE THAT FK506 AND RAPAMYCIN BLOCK T-CELL ACTIVATION AT DIFFERENT SITES RELATIVE TO EARLY REVERSIBLE PHOSPHORYLATION INVOLVING THE PROTEIN PHOSPHATASES PP1 AND PP2A TRANSPLANTATION. 1991 JUN; 51 (6): 1318-1320	0	19	1	20
1686	2717 Metes D, Logar A, Rudert WA, Zeevi A, Woodward J, et al. Four-color flow cytometric analysis of peripheral blood donor cell chimerism HUMAN IMMUNOLOGY. 2003 AUG; 64 (8): 787-795	6	10	15	25
1687	2264 Meyer D, Loffeler S, Otto C, Gassel HJ, Timmermann W, et al. Donor cell population in the liver allograft reflects the recipient immune status TRANSPLANTATION PROCEEDINGS. 1999 FEB-MAR; 31 (1-2): 437-437	1	1	3	6
1688	2378 Meyer D, Loffeler S, Otto C, Czub S, Gassel HJ, et al. Donor-derived alloantigen-presenting cells persist in the liver allograft during tolerance induction TRANSPLANT INTERNATIONAL. 2000 JAN; 13 (1): 12-20	1	8	24	47
1689	2951 Meyer NJ, Bhorade SM Evolving immunosuppressive regimens for lung transplant recipients SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. 2006 OCT; 27 (5): 470-479	0	2	5	107
1690	632 MEYERS AM, RICE GC, KAYE S, MYBURGH JA, RABKIN R KAPOSIS SARCOMA IN AN IMMUNOSUPPRESSED RENAL-ALLOGRAFT RECIPIENT SOUTH AFRICAN MEDICAL JOURNAL. 1976; 50 (33): 1299-1300	0	4	1	19
#	Date / Author / Journal	LCS	GCS	LCR	CR
1691	681 MEYERS WC, HARRIS N, STEIN S, BROOKS M, JONES RS, et al. ALIMENTARY-TRACT COMPLICATIONS AFTER RENAL-TRANSPLANTATION ANNALS OF SURGERY. 1979; 190 (4): 535-542	1	45	4	36
1692	2781 Mezrich J, Yamada K, Sachs DH, Madsen JC Regulatory T cells generated by the kidney may mediate the beneficial immune effects of combining kidney with heart transplantation SURGERY. 2004 MAY; 135 (5): 473-478	0	6	3	25
1693	2950 Miao LN, Sun J, Yuan H, Jia Y, Xu ZG Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation NEPHROLOGY. 2006 OCT; 11 (5): 449-454	0	2	3	20
1694	169 MICHAEL AF, VERNIER RL, DRUMMOND KN, LEVITT JI, HERDMAN RC, et al. IMMUNOSUPPRESSIVE THERAPY OF CHRONIC RENAL DISEASE NEW ENGLAND JOURNAL OF MEDICINE. 1967; 276 (15): 817-&	6	126	1	27
1695	591 MICHEL RP, GUTTMANN RD, KNAACK J, KLASSEN J, BEAUDOIN JG, et al. ANTILYMPHOCYTE GLOBULIN IN RENAL-TRANSPLANTATION ARCHIVES OF SURGERY. 1975; 110 (1): 90-93	0	12	7	40
1696	2885 Middleton SJ, Jamieson NV The current status of small bowel transplantation in the UK and internationally GUT. 2005 NOV; 54 (11): 1650-1657	2	12	11	75
1697	3001 Middleton SJ Is intestinal transplantation now an alternative to home parenteral nutrition? PROCEEDINGS OF THE NUTRITION SOCIETY. 2007 AUG; 66 (3): 316-320	0	3	3	27
1698	2446 Midha R, Ramakrishna V, Munro CA, Matsuyama T, Gorczynski RM Detection of host and donor cells in sex-mismatched rat nerve allografts using RT-PCR for a Y chromosome (H-Y) marker JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2000 SEP; 5 (3): 140-146	0	2	3	43
1699	2116 Midtvedt K, Hartmann A, Hjelmesaeth J, Lund K, Bjerkely BL Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients NEPHROLOGY DIALYSIS TRANSPLANTATION. 1998 FEB; 13 (2): 427-431	2	41	5	26
1700	1048 MIELES L, TODO S, FUNG JJ, JAIN A, FURUKAWA H, et al. ORAL GLUCOSE-TOLERANCE TEST IN LIVER RECIPIENTS TREATED WITH FK-506 TRANSPLANTATION PROCEEDINGS. 1990 FEB; 22 (1): 41-43	19	29	3	8

Date / Author / Journal

LCS

GCS

LCR

1601

2536 Matas AJ, Payne WD, Sutherland DER, Humar A, Gruessner RWG, et al.

2,500 living donor kidney transplants: A single-center experience

ANNALS OF SURGERY. 2001 AUG; 234 (2): 149-164

1602

2547 Matas AJ, Ramcharan T, Paraskevas S, Gillingham KJ, Dunn DL, et al.

Rapid discontinuation of steroids in living donor kidney transplantation: A pilot study

AMERICAN JOURNAL OF TRANSPLANTATION. 2001 SEP; 1 (3): 278-283

1603

2796 Matas AJ, Kandaswamy R, Humar A, Payne WD, Dunn DL, et al.

Long-term immunosuppression, without maintenance prednisone, after kidney transplantation

ANNALS OF SURGERY. 2004 SEP; 240 (3): 510-516

1604

1777 Mathe G

Will killing the last HIV1 particle cure AIDS patients? Doesn't CMV activation and/or a graft-versus-host component of the disease, also have to be considered? .1. First of two parts

BIOMEDICINE & PHARMACOTHERAPY. 1996; 50 (5): 185-206

140

1605

2621 Mathes DW, Randolph MA, Bourget JL, Nielsen GP, Ferrera VR, et al.

Recipient bone marrow engraftment in donor tissue after long-term tolerance to a composite tissue allograft

TRANSPLANTATION. 2002 JUN 27; 73 (12): 1880-1885

1606

1994 Mathew JM, Carreno M, Fuller L, Ricordi C, Tzakis AG, et al.

Modulatory effects of human donor bone marrow cells on allogeneic cellular immune responses

TRANSPLANTATION. 1997 MAR 15; 63 (5): 686-692

1607

2137 Mathew JM, Carreno M, Zucker K, Fuller L, Kenyon N, et al.

Cellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantation

TRANSPLANTATION. 1998 APR 15; 65 (7): 947-955

1608

2158 Mathew JM, Carreno M, Zucker K, Fuller L, Vallone T, et al.

Differential resistance of the cellular immune responses and immunoregulatory properties of human cadaveric donor bone marrow cells to immunosuppressive drugs commonly used in transplantation

TRANSPLANTATION PROCEEDINGS. 1998 JUN; 30 (4): 1073-1074

1609

2344 Mathew JM, Carreno M, Fuller L, Ricordi C, Kenyon N, et al.

In vitro immunogenicity of cadaver donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation

TRANSPLANTATION. 1999 OCT 27; 68 (8): 1172-1180

1610

2469 Mathew JM, Garcia-Morales R, Fuller L, Rosen A, Ciancio G, et al.

Donor bone marrow-derived chimeric cells present in renal, transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses

TRANSPLANTATION. 2000 DEC 27; 70 (12): 1675-1682

Date / Author / Journal

LCS

GCS

LCR

1611

2470 Mathew JM, Fuller L, Carreno M, Garcia-Morales R, Burke GW, et al.

Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses

TRANSPLANTATION. 2000 DEC 27; 70 (12): 1752-1760

1612

2530 Mathew JM, Miller J

Immunoregulatory role of chimerism in clinical organ transplantation

BONE MARROW TRANSPLANTATION. 2001 JUL; 28 (2): 115-119

1613

2637 Mathew JM, Carreno M, Fuller L, Burke GW, Ciancio G, et al.

Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparations used in clinical organ transplantation

TRANSPLANTATION. 2002 SEP 27; 74 (6): 846-855

1614

2715 Mathew JM, Garcia-Morales RO, Carreno M, Jin YD, Fuller L, et al.

Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation

TRANSPLANT IMMUNOLOGY. 2003 JUL-SEP; 11 (3-4): 307-321

1615

3065 Mathew JM, Blomberg B, Ricordi C, Esquenazi V, Miller J

Evaluation of the tolerogenic effects of donor bone marrow cells using a severe combined immunodeficient mouse-human islet transplant model

HUMAN IMMUNOLOGY. 2008 OCT; 69 (10): 605-613

1616

3154 Mathew JM, Ciancio G, Burke GW, Garcia-Morales RO, Rosen A, et al.

Immune "tolerance profiles" in donor bone marrow infused kidney transplant patients using multiple ex vivo functional assays

HUMAN IMMUNOLOGY. 2010 JUN; 71 (6): 566-576

1617

3194 Mathew JM, Leventhal JR, Miller J

Microchimerism in promoting graft acceptance in clinical transplantation

CURRENT OPINION IN ORGAN TRANSPLANTATION. 2011 AUG; 16 (4): 345-352

1618

1388 MATHEWS KA, GALLIVAN GJ, MALLARD BA

CLINICAL, BIOCHEMICAL, AND HEMATOLOGIC EVALUATION OF NORMAL DOGS AFTER ADMINISTRATION OF RABBIT ANTI-DOG THYMOCYTE SERUM

VETERINARY SURGERY. 1993 MAY-JUN; 22 (3): 213-220

1619

1113 MATHIESON PW, REES AJ

CHANGING VIEWS ON THE TREATMENT OF GLOMERULONEPHRITIS

INTERNATIONAL YEARBOOK OF NEPHROLOGY. 1991; : 73-95

175

1620

1987 Mathieu C, Casteels K, Bouillon R, Waer M

Protection against autoimmune diabetes in mixed bone marrow chimeras - Mechanisms involved

JOURNAL OF IMMUNOLOGY. 1997 FEB 1; 158 (3): 1453-1457

Date / Author / Journal

LCS

GCS

LCR

1621

2245 Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, et al.

Impact of hepatitis B and C virus on kidney transplantation outcome

HEPATOLOGY. 1999 JAN; 29 (1): 257-263

270

1622

1465 MATSUNAMI H, TADA A, MAKUUCHI M, LYNCH SV, STRONG RW

NEW TECHNIQUE FOR MEASURING TACROLIMUS CONCENTRATIONS IN BLOOD

AMERICAN JOURNAL OF HOSPITAL PHARMACY. 1994 JAN; 51 (1): 123-123

1623

1216 MATSUURA T, SHINOHARA Y, HARA Y, IMANISHI M, NISHIOKA T, et al.

BENEFICIAL IMMUNOSUPPRESSIVE EFFECT OF COMBINED USE OF FK-506 AND CYCLOSPORINE ASSESSED BY PROLIFERATIVE RESPONSES OF CLONED HUMAN T-CELLS

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 2931-2932

1624

1270 MATSUURA T, NEGITA M, IKEGAMI M, IMANISHI M, NISHIOKA T, et al.

BLOCKADE OF INTERLEUKIN-2 PRODUCTION FROM CLONED T-CELLS BY CYCLOSPORINE AND FK-506 ASSESSED BY PROLIFERATION ASSAYS INVITRO

TRANSPLANTATION PROCEEDINGS. 1992 FEB; 24 (1): 410-412

1625

1456 MATSUURA T, HARA Y, IMANISHI M, KANDA H, KURITA T

PROLONGED SURVIVAL OF RAT CARDIAC ALLOGRAFTS INDUCED BY INTRATHYMIC INJECTION OF DONOR BONE-MARROW CELLS

TRANSPLANTATION PROCEEDINGS. 1993 DEC; 25 (6): 3283-3285

1626

2043 Matsuura T, Imanishi M, Hara Y, Nishioka T, Kunikata S, et al.

Suppressed alloreactivity and mixed chimerism in rats with accepted cardiac allografts by intrathymic injection of donor bone marrow cells

TRANSPLANT INTERNATIONAL. 1997 JUL; 10 (4): 262-267

1627

2335 Matteucci E, Carmellini M, Mosca F, Giampietro O

The contribution of Na+/H+ exchange to postreperfusion injury and recovery of transplanted kidney

BIOMEDICINE & PHARMACOTHERAPY. 1999 OCT; 53 (9): 438-444

1628

2148 Mayr WR, Glock B

DNA typing of patients with potentially modified patterns in peripheral blood

TRANSFUSION. 1998 MAY; 38 (5): 510-510

1629

1862 Mayumi H, Umesue M, Nomoto K

Cyclophosphamide-induced immunological tolerance: An overview

IMMUNOBIOLOGY. 1996 JUL; 195 (2): 129-139

1630

1643 MAZARIEGOS GV, RAMOS H, SHAPIRO R, ZEEVI A, FUNG JJ, et al.

WEANING OF IMMUNOSUPPRESSION IN LONG-TERM RECIPIENTS OF LIVING-RELATED RENAL-TRANSPLANTS - A PRELIMINARY-STUDY

TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 207-209

Date / Author / Journal

LCS

GCS

LCR

1631

1951 Mazariegos GV, Reyes J, Marino IR, Demetris AJ, Flynn B, et al.

Weaning of immunosuppression in liver transplant recipients

TRANSPLANTATION. 1997 JAN 27; 63 (2): 243-249

207

1632

1975 Mazariegos GV, Reyes J, Marino I, Flynn B, Fung JJ, et al.

Risks and benefits of weaning immunosuppression in liver transplant recipients: Long-term follow-up

TRANSPLANTATION PROCEEDINGS. 1997 FEB-MAR; 29 (1-2): 1174-1177

1633

2427 Mazariegos GV, Salzedas AA, Zavatsky J, Sindhi R, Parizhskaya M, et al.

Long term management of liver transplant rejection in children

BIODRUGS. 2000 JUL; 14 (1): 31-48

1634

2707 Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L, Flynn B, et al.

Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients

AMERICAN JOURNAL OF TRANSPLANTATION. 2003 JUN; 3 (6): 689-696

1635

2787 Mazariegos GV

Withdrawal of immunosuppression in liver transplantation: Lessons learned from PTLD

PEDIATRIC TRANSPLANTATION. 2004 JUN; 8 (3): 210-213

1636

2795 Mazariegos GV, Abu-Elmagd K, Jaffe R, Bond G, Sindhi R, et al.

Graft versus host disease in intestinal transplantation

AMERICAN JOURNAL OF TRANSPLANTATION. 2004 SEP; 4 (9): 1459-1465

1637

2947 Mazariegos GV

Tolerogenic immunosuppression in pediatric abdominal transplantation

CURRENT OPINION IN ORGAN TRANSPLANTATION. 2006 OCT; 11 (5): 537-542

1638

2972 Mazariegos GV, Sindhi R, Thomson AW, Marcos A

Clinical tolerance following liver transplantation: Long term results and future prospects

TRANSPLANT IMMUNOLOGY. 2007 FEB; 17 (2): 114-119

1639

1055 MAZZAFERRO V, SCOTTIFOGLIENI CL, PORTER KA, BELLIDO JT, CARRIERI G, et al.

STUDIES OF THE HEPATOTROPHIC QUALITIES OF FK-506 AND CYA

TRANSPLANTATION PROCEEDINGS. 1990 FEB; 22 (1): 93-95

1640

1815 Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, et al.

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

NEW ENGLAND JOURNAL OF MEDICINE. 1996 MAR 14; 334 (11): 693-699

2143

Date / Author / Journal

1641

Genetic algorithms for modelling and optimisation

JOURNAL OF COMPUTATIONAL AND APPLIED MATHEMATICS. 2005 DEC 1; 184 (1): 205-222

1642

2602 McCaughan GW

Withdrawal of immunosuppression in liver transplant recipients: Is this as good as it gets?

LIVER TRANSPLANTATION. 2002 APR; 8 (4): 408-410

1643

1025 MCCAULEY J, BRONSTHER O, Fung JJ, TODO S, STARZL TE

TREATMENT OF CYCLOSPORIN-INDUCED HEMOLYTIC UREMIC SYNDROME WITH FK506

LANCET. 1989 DEC 23; 2 (8678-9): 1516-1516

1644

1045 MCCAULEY J, Fung JJ, JAIN A, TODO S, STARZL TE

THE EFFECTS OF FK-506 ON RENAL-FUNCTION AFTER LIVER-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1990 FEB; 22 (1): 17-20

1645

1148 MCCAULEY J, TAKAYA S, Fung JJ, Tzakis AG, ABUELMAGD K, et al.

THE QUESTION OF FK506 NEPHROTOXICITY AFTER LIVER-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1991 FEB; 23 (1): 1444-1447

1646

1239 MCCAULEY J, FUNG JJ, TODO S, JAIN A, DEBALLI P, et al.

CHANGES IN RENAL-FUNCTION AFTER LIVER-TRANSPLANTATION UNDER FK-506

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3143-3145

1647

1254 MCCAULEY J, SHAPIRO R, SCANTLEBURY V, GILBOA N, JORDAN M, et al.

FK-506 IN THE MANAGEMENT OF TRANSPLANT-RELATED NEPHROTIC SYNDROME AND STEROID-RESISTANT NEPHROTIC SYNDROME

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3354-3356

1648

2828 McCauley J

Steroid-free lymphocyte depletion protocols - The potential for partial tolerance?

KIDNEY TRANSPLANTATION : STRATEGIES TO PREVENT ORGAN REJECTION. 2005; 146: 43-53

1649

1520 MCCHESNEY LP, XIAO F, SANKARY HN, FOSTER PF, SHARMA S, et al.

AN EVALUATION OF LEFLUNOMIDE IN THE CANINE RENAL-TRANSPLANTATION MODEL

TRANSPLANTATION. 1994 JUN 27; 57 (12): 1717-1722

1650

2874 McCurry KR, Iacono A, Zeevi A, Yousem S, Girnita A, et al.

Early outcomes in human lung transplantation with thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 2005 AUG; 130 (2): 528-537

Date / Author / Journal

LCS

GCS

LCR

1651

2931 McCurry KR, Colvin BL, Zahorchak AF, Thomson AW

Regulatory dendritic cell therapy in organ transplantation

TRANSPLANT INTERNATIONAL. 2006 JUL; 19 (7): 525-538

115

1652

1224 MCDIARMID SV, KLINTMALM G, BUSUTTIL RW

FK-506 RESCUE THERAPY IN LIVER-TRANSPLANTATION - OUTCOME AND COMPLICATIONS

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 2996-2999

1653

1437 MCDIARMID SV, COLONNA JO, SHAKED A, AMENT ME, BUSUTTIL RW

A COMPARISON OF RENAL-FUNCTION IN CYCLOSPORINE-TREATED AND FK-506-TREATED PATIENTS AFTER PRIMARY ORTHOTOPIC LIVER-TRANSPLANTATION

TRANSPLANTATION. 1993 OCT; 56 (4): 847-853

1654

1677 MCDIARMID SV, WALLACE P, VARGAS J, AMENT ME, BUSUTTIL RW

THE TREATMENT OF INTRACTABLE REJECTION WITH TACROLIMUS (FK506) IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 1995 APR; 20 (3): 291-299

1655

2108 McDiarmid SV

The use of tacrolimus in pediatric liver transplantation

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 1998 JAN; 26 (1): 90-102

1656

2740 McDiarmid SV

Current status of liver transplantation in children

PEDIATRIC CLINICS OF NORTH AMERICA. 2003 DEC; 50 (6): 1335-+

265

1657

1690 MCDONALD JC

IN SEARCH OF THE HOLY-GRAIL (ACTIVELY ACQUIRED IMMUNOLOGICAL-TOLERANCE)

ANNALS OF SURGERY. 1995 MAY; 221 (5): 439-445

1658

2065 McDonald JC, Adamashvili I, Zibari GB, Aultman DF, Mancini MC, et al.

Serologic allogeneic chimerism

TRANSPLANTATION. 1997 SEP 27; 64 (6): 865-871

1659

926 MCENERY PT, FINE R, ASCHER N, ETTENGER R, CONLEY S, et al.

RENAL-TRANSPLANT IMMUNITY AND IMMUNOSUPPRESSION

AMERICAN JOURNAL OF KIDNEY DISEASES. 1986 APR; 7 (4): 312-317

1660

1285 MCGOON MD, FRANTZ RP

TECHNIQUES OF IMMUNOSUPPRESSION AFTER CARDIAC TRANSPLANTATION

MAYO CLINIC PROCEEDINGS. 1992 JUN; 67 (6): 586-595

Date / Author / Journal

LCS

GCS

LCR

1661

602 MCGRATH BP, IBELS LS, RAIK E, HARGRAVE M, MAHONY JF, et al.

ERYTHROID TOXICITY OF AZATHIOPRINE - MACROCYTOSIS AND SELECTIVE MARROW HYPOPLASIA

QUARTERLY JOURNAL OF MEDICINE. 1975; 44 (173): 57-63

1662

2011 McKee M, Segev D, Wise B, Case B, Neu A, et al.

Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients

JOURNAL OF PEDIATRIC SURGERY. 1997 MAY; 32 (5): 688-690

1663

237 MCKENZIE IF, STOCKER J, TING A, MORRIS PJ

HUMAN LYMPHOCYTOTOXIC AND HAEMAGGLUTINATING ACTIVITY AGAINST SHEEP AND PIG CELLS

LANCET. 1968; 2 (7564): 386-&

1664

823 MCMASTER P, HAYNES IG, MICHAEL J, ADU D, VLASSIS T, et al.

CYCLOSPORINE IN CADAVERIC RENAL-TRANSPLANTATION - A PROSPECTIVE RANDOMIZED TRIAL

TRANSPLANTATION PROCEEDINGS. 1983; 15 (4): 2523-2527

1665

1426 MCMASTER P, BUIST L

FK-506 IN TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 AUG; 25 (4): 2684-2685

1666

1760 MCMASTER P, MIRZA DF, ISMAIL T, VENNARECCI G, PATAPIS P, et al.

THERAPEUTIC DRUG-MONITORING OF TACROLIMUS IN CLINICAL TRANSPLANTATION

THERAPEUTIC DRUG MONITORING. 1995 DEC; 17 (6): 602-605

1667

1411 MCMICHAEL J, LIEBERMAN R, DOYLE H, MCCAULEY J, Fung JJ, et al.

AN INTELLIGENT AND COST-EFFECTIVE COMPUTER DOSING SYSTEM FOR INDIVIDUALIZING FK506 THERAPY IN TRANSPLANTATION AND AUTOIMMUNE DISORDERS

JOURNAL OF CLINICAL PHARMACOLOGY. 1993 JUL; 33 (7): 599-605

1668

1750 MCNAIR ANB, TIBBS CJ, WILLIAMS R

RECENT ADVANCES - HEPATOLOGY

BRITISH MEDICAL JOURNAL. 1995 NOV 18; 311 (7016): 1351-1355

1669

400 MCPHAUL JJ, DIXON FJ, BRETTSCH.L, STARZL TE

IMMUNOFLUORESCENT EXAMINATION OF BIOPSIES FROM LONG-TERM RENAL ALLOGRAFTS

NEW ENGLAND JOURNAL OF MEDICINE. 1970; 282 (8): 412-&

1670

3088 McShane PJ, Garrity ER

Minimization of immunosuppression after lung transplantation: current trends

TRANSPLANT INTERNATIONAL. 2009 JAN; 22 (1): 90-95

Date / Author / Journal

LCS

GCS

LCR

1671

1936 McSherry C, Jackson A, Hertz MI, Boltman R, Savik K, et al.

Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function

TRANSPLANTATION. 1996 DEC 27; 62 (12): 1811-1818

1672

3049 Mehrabi A, Fonouni H, Muller SA, Schmidt J

Current concepts in transplant surgery: liver transplantation today

LANGENBECKS ARCHIVES OF SURGERY. 2008 MAY; 393 (3): 245-260

1673

3132 Mehrabi A, Fonouni H, Ayoub E, Rahbari NN, Muller SA, et al.

A single center experience of combined liver kidney transplantation

CLINICAL TRANSPLANTATION. 2009 DEC; 23: 102-114

153

1674

2355 Mehta P, Beltz S, Kedar A, Graham-Pole J, Wingard JR

Increased clearance of tacrolimus in children: need for higher doses and earlier initiation prior to bone marrow transplantation

BONE MARROW TRANSPLANTATION. 1999 DEC; 24 (12): 1323-1327

1675

1417 MEISER B, REICHART B

GRAFT VESSEL DISEASE - THE IMPACT OF IMMUNOSUPPRESSION AND POSSIBLE TREATMENT STRATEGIES

IMMUNOLOGICAL REVIEWS. 1993 AUG; 134: 99-116

1676

2361 Melief CJM, Toes REM, Medema JP, Van der Burg SH, Ossendorp F, et al.

Strategies for immunotherapy of cancer

ADVANCES IN IMMUNOLOGY, VOL 75. 2000; 75: 235-282

122

283

1677

375 MEMPEL W, THIERFEL.S

EFFECT OF ANTILYMPHOCYTE SERUM ALONE OR IN CONNECTION WITH A CYTOSTATICUM ON A LEUKEMIA OF MICE

BLUT. 1970; 20 (1): 37-&

1678

928 MENDEZ R, KOUSSA N, ALANIZI A, MENDEZ RG, IWAKI Y, et al.

PERIOPERATIVE CYCLOSPORINE - INTERACTION WITH MULTIFACTORIAL VARIABLES AND EFFECT ON ALLOGRAFT FUNCTION

TRANSPLANTATION PROCEEDINGS. 1986 APR; 18 (2): 12-15

1679

361 MERIEL

ANESTHESIA ON NEPHRITIC PATIENT

ANESTHESIE ANALGESIE REANIMATION. 1970; 27 (2): 241-&

1680

815 MERION RM, WHITE DJG, CALNE RY

EARLY RENAL-ALLOGRAFT REJECTION EPISODES ARE LESS AGGRESSIVE WITH CYCLOSPORIN-A IMMUNOSUPPRESSION

TRANSPLANTATION PROCEEDINGS. 1983; 15 (4): 2172-2177

Date / Author / Journal

LCS

GCS

LCR

1681

863 MERION RM, WHITE DJG, THIRU S, EVANS DB, CALNE RY

CYCLOSPORINE - 5 YEARS EXPERIENCE IN CADAVERIC RENAL-TRANSPLANTATION

NEW ENGLAND JOURNAL OF MEDICINE. 1984; 310 (3): 148-154

386

1682

634 MERKEL FK, STRAUS AK, ANDERSEN O, BANNETT AD

MICROVASCULAR TECHNIQUES FOR POLAR ARTERY RECONSTRUCTION IN KIDNEY-TRANSPLANTS

SURGERY. 1976; 79 (3): 253-261

1683

64 MERRILL JP

EXPERIENCE IN RENAL TRANSPLANTATION

NEW ENGLAND JOURNAL OF MEDICINE. 1965; 272 (21): 1134-&

1684

114 MERRILL JP, FLAX MH, PIER AS, CANELLOS GP, LEAF A, et al.

WEEKLY CLINICOPATHOLOGICAL EXERCISES - CASE 43-1966

NEW ENGLAND JOURNAL OF MEDICINE. 1966; 275 (13): 721-&

1685

1172 METCALFE S, MILNER J

EVIDENCE THAT FK506 AND RAPAMYCIN BLOCK T-CELL ACTIVATION AT DIFFERENT SITES RELATIVE TO EARLY REVERSIBLE PHOSPHORYLATION INVOLVING THE PROTEIN PHOSPHATASES PP1 AND PP2A

TRANSPLANTATION. 1991 JUN; 51 (6): 1318-1320

1686

2717 Metes D, Logar A, Rudert WA, Zeevi A, Woodward J, et al.

Four-color flow cytometric analysis of peripheral blood donor cell chimerism

HUMAN IMMUNOLOGY. 2003 AUG; 64 (8): 787-795

1687

2264 Meyer D, Loffeler S, Otto C, Gassel HJ, Timmermann W, et al.

Donor cell population in the liver allograft reflects the recipient immune status

TRANSPLANTATION PROCEEDINGS. 1999 FEB-MAR; 31 (1-2): 437-437

1688

2378 Meyer D, Loffeler S, Otto C, Czub S, Gassel HJ, et al.

Donor-derived alloantigen-presenting cells persist in the liver allograft during tolerance induction

TRANSPLANT INTERNATIONAL. 2000 JAN; 13 (1): 12-20

1689

2951 Meyer NJ, Bhorade SM

Evolving immunosuppressive regimens for lung transplant recipients

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. 2006 OCT; 27 (5): 470-479

107

1690

632 MEYERS AM, RICE GC, KAYE S, MYBURGH JA, RABKIN R

KAPOSIS SARCOMA IN AN IMMUNOSUPPRESSED RENAL-ALLOGRAFT RECIPIENT

SOUTH AFRICAN MEDICAL JOURNAL. 1976; 50 (33): 1299-1300

Date / Author / Journal

LCS

GCS

LCR

1691

681 MEYERS WC, HARRIS N, STEIN S, BROOKS M, JONES RS, et al.

ALIMENTARY-TRACT COMPLICATIONS AFTER RENAL-TRANSPLANTATION

ANNALS OF SURGERY. 1979; 190 (4): 535-542

1692

2781 Mezrich J, Yamada K, Sachs DH, Madsen JC

Regulatory T cells generated by the kidney may mediate the beneficial immune effects of combining kidney with heart transplantation

SURGERY. 2004 MAY; 135 (5): 473-478

1693

2950 Miao LN, Sun J, Yuan H, Jia Y, Xu ZG

Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation

NEPHROLOGY. 2006 OCT; 11 (5): 449-454

1694

169 MICHAEL AF, VERNIER RL, DRUMMOND KN, LEVITT JI, HERDMAN RC, et al.

IMMUNOSUPPRESSIVE THERAPY OF CHRONIC RENAL DISEASE

NEW ENGLAND JOURNAL OF MEDICINE. 1967; 276 (15): 817-&

126

1695

591 MICHEL RP, GUTTMANN RD, KNAACK J, KLASSEN J, BEAUDOIN JG, et al.

ANTILYMPHOCYTE GLOBULIN IN RENAL-TRANSPLANTATION

ARCHIVES OF SURGERY. 1975; 110 (1): 90-93

1696

2885 Middleton SJ, Jamieson NV

The current status of small bowel transplantation in the UK and internationally

GUT. 2005 NOV; 54 (11): 1650-1657

1697

3001 Middleton SJ

Is intestinal transplantation now an alternative to home parenteral nutrition?

PROCEEDINGS OF THE NUTRITION SOCIETY. 2007 AUG; 66 (3): 316-320

1698

2446 Midha R, Ramakrishna V, Munro CA, Matsuyama T, Gorczynski RM

Detection of host and donor cells in sex-mismatched rat nerve allografts using RT-PCR for a Y chromosome (H-Y) marker

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2000 SEP; 5 (3): 140-146

1699

2116 Midtvedt K, Hartmann A, Hjelmesaeth J, Lund K, Bjerkely BL

Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients

NEPHROLOGY DIALYSIS TRANSPLANTATION. 1998 FEB; 13 (2): 427-431

1700

1048 MIELES L, TODO S, FUNG JJ, JAIN A, FURUKAWA H, et al.

ORAL GLUCOSE-TOLERANCE TEST IN LIVER RECIPIENTS TREATED WITH FK-506

TRANSPLANTATION PROCEEDINGS. 1990 FEB; 22 (1): 41-43

The Kidney Transplant Papers 9 papers representing Starzl's ground breaking work in the area of kidney transplantation. And all the papers citing them from the SCI, AHCI, SSCI databases up-to-date as of May 2012	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012
List of All Records